…
BioLife Sciences Inc. develops, licenses, and commercializes products and technologies for the healthcare, beauty, and food and beverage industries. It also offers orthomolecular products. The company is based in Henderson, Nevada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
BioLife Sciences Inc (BLFE) is quoted on the OTC Pink; public disclosures provide limited detail on its core operations and product portfolio. Long-term growth may depend on successful product development, regulatory progress, strategic partnerships and additional financing, and the company may benefit if execution and transparency improve, making it more accessible to investors.
Material risks include limited public information and regulatory transparency, low trading liquidity typical of OTC Pink listings, likely need for additional capital, and execution and regulatory risks common to small, early-stage life‑sciences companies.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2022-11-30 | 2021-11-30 | 2020-11-30 | 2019-11-30 | 2018-11-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-11-30 | 2021-11-30 | 2020-11-30 | 2019-11-30 | 2018-11-30 |
| Income before tax | - | - | - | -0.00M | -0.05M |
| Net income | - | - | - | -0.00M | -0.05M |
| Ebit | - | -0.42M | -1.27M | 0.00M | - |
| Ebitda | - | - | - | 0.17M | -0.04M |
| Depreciation and amortization | 0.23M | - | - | 0.17M | - |
| Operating income | - | - | - | - | -0.04M |
| Other operating expenses | - | - | - | - | 0.04M |
| Interest expense | - | 0.00M | 0.00M | - | 0.01M |
| Total operating expenses | - | - | - | - | 0.04M |
| Total other income expense net | - | - | - | -0.00M | -0.01M |
| Net income applicable to common shares | - | -0.46M | -1.27M | - | - |
| Breakdown | 2021-11-30 | 2020-11-30 | 2019-11-30 | 2018-11-30 | 2017-11-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2021-11-30 | 2020-11-30 | 2019-11-30 | 2018-11-30 | 2017-11-30 |
| Total assets | - | - | 0.00M | 0.00M | 0.01M |
| Total liab | - | - | 0.00M | 0.22M | 0.20M |
| Total stockholder equity | - | - | -0.00M | -0.22M | -0.18M |
| Other current liab | 0.09M | 0.08M | 0.00M | - | 0.05M |
| Common stock | 0.01M | 0.01M | - | 0.35M | 0.33M |
| Retained earnings | -1.73M | -1.27M | -0.00M | -4.89M | -4.84M |
| Cash | - | - | 0.00M | 0.00M | 0.01M |
| Total current liabilities | 1.07M | 0.84M | 0.00M | 0.16M | 0.13M |
| Net debt | - | - | -0.00M | 0.14M | 0.13M |
| Short term debt | - | - | - | 0.08M | 0.07M |
| Short long term debt total | - | - | - | 0.14M | 0.14M |
| Other stockholder equity | -0.01M | -0.04M | - | 4.33M | 4.66M |
| Property plant equipment | 0.12M | 0.20M | - | - | - |
| Total current assets | 0.08M | 0.07M | 0.00M | 0.00M | 0.01M |
| Net tangible assets | -0.88M | -0.69M | - | - | - |
| Accounts payable | 0.58M | 0.49M | - | 0.08M | - |
| Accumulated other comprehensive income | - | - | - | - | -0.33M |
| Breakdown | 2021-11-30 | 2020-11-30 | 2019-11-30 | 2018-11-30 | 2017-11-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2021-11-30 | 2020-11-30 | 2019-11-30 | 2018-11-30 | 2017-11-30 |
| Change to liabilities | 0.21M | 0.30M | - | - | - |
| Total cashflows from investing activities | - | -0.00M | - | - | - |
| Net borrowings | 0.07M | 0.88M | - | - | - |
| Total cash from financing activities | 0.07M | 0.99M | - | 0.00M | 0.03M |
| Change to operating activities | -0.02M | -0.04M | - | - | - |
| Net income | -0.46M | -1.27M | -0.00M | -0.05M | -0.34M |
| Change in cash | -0.02M | 0.03M | -0.00M | -0.01M | 0.01M |
| Begin period cash flow | - | 0.40M | 0.00M | 0.01M | - |
| End period cash flow | - | - | 0.00M | 0.00M | 0.01M |
| Total cash from operating activities | -0.11M | -1.00M | 0.00M | -0.01M | -0.02M |
| Change to inventory | - | 0.00M | - | - | - |
| Other cashflows from financing activities | - | 0.88M | - | 0.00M | 0.03M |
| Change to netincome | 0.16M | 0.00M | - | - | - |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | - | - | 0.00M | 0.03M | 0.02M |
| Other non cash items | - | - | -0.00M | -0.01M | 0.30M |
| Free cash flow | - | - | 0.00M | -0.01M | -0.02M |
Sector: Healthcare Industry: Medical Instruments & Supplies
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BLFE BioLife Sciences Inc |
- -% |
0.00 | - | - | 0.00 | - | 0.13 | 9.15 |
| ISRG Intuitive Surgical Inc |
-8.32 2.04% |
398.92 | 43.30 | 31.35 | 12.25 | 7.35 | 11.63 | 30.22 |
| ESLOF EssilorLuxottica Société anonyme |
-2.84 1.45% |
192.96 | 44.84 | 27.62 | 4.07 | 2.49 | 3.71 | 16.04 |
| ESLOY Essilor International SA |
-1.82 1.88% |
95.04 | 41.68 | 27.25 | 3.94 | 2.45 | 3.71 | 16.04 |
| BDX Becton Dickinson and Company |
0.10 0.05% |
212.78 | 31.62 | 13.76 | 2.25 | 2.04 | 2.93 | 13.40 |
BioLife Sciences Inc. develops, licenses, and commercializes products and technologies for the healthcare, beauty, and food and beverage industries. It also offers orthomolecular products. The company is based in Henderson, Nevada.
2831 Saint Rose Parkway, Henderson, NV, United States, 89052
833-919-1037
| Name | Title | Year Born |
|---|---|---|
| Mr. Justin De Four | Founder, CEO & Chairman | 1990 |
| Mr. Colton De Gooyer | Director of Operations | NA |
| Ms. Nika Jaksic | COO & Director | 1980 |
| Ms. Nika Jaksic | COO & Director | 1981 |
| Mr. Justin De Four | Founder, CEO & Chairman | 1991 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.